Treatment Options for Migraine Headaches
The first-line treatment for moderate to severe migraine headaches should begin with NSAIDs or acetaminophen, followed by adding a triptan if adequate relief is not achieved. 1, 2
Stepwise Treatment Approach
First-Line Treatments
- For mild to moderate migraine:
Second-Line Treatments
- For moderate to severe migraine or inadequate response to first-line:
Third-Line Treatments
- For patients who don't respond to or cannot tolerate combination therapy:
Important Clinical Considerations
Medication Selection
Route of administration:
Timing of medication:
- Begin treatment as early as possible after onset of migraine 1
- Early intervention improves efficacy
Medication switching:
- If one medication in a class fails, try another in the same class before moving to next line 1
- Example: If one triptan is ineffective, try another before moving to CGRP antagonists
Cautions and Contraindications
- Avoid opioids and butalbital for migraine treatment 1
- Medication overuse headache risk:
- Triptan contraindications:
- Risk of serotonin syndrome with triptans, especially when combined with SSRIs, SNRIs, TCAs, or MAOIs 4
Non-Pharmacological Approaches
Lifestyle modifications:
Behavioral interventions:
- Cognitive-behavioral therapy
- Biofeedback
- Relaxation training
- Mindfulness practices 2
Prevention Considerations
Consider preventive treatment when:
Preventive medication options:
- Beta-blockers (propranolol 80-240 mg/day, timolol 20-30 mg/day)
- Tricyclic antidepressants (amitriptyline 30-150 mg/day)
- Anticonvulsants (divalproex sodium 500-1500 mg/day) 2
Common Pitfalls to Avoid
Inadequate dosing: Ensure appropriate doses of NSAIDs or acetaminophen before concluding they are ineffective 1
Delayed treatment: Starting treatment late in the migraine attack reduces effectiveness 1
Medication overuse: Using acute medications too frequently can lead to medication overuse headache 1, 2
Ignoring cardiovascular risk: Triptans should be used cautiously in patients with cardiovascular risk factors 4, 5
Failure to address comorbidities: Nausea, vomiting, and sensory sensitivities should be specifically targeted 2